vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Walker & Dunlop, Inc. (WD). Click either name above to swap in a different company.
Walker & Dunlop, Inc. is the larger business by last-quarter revenue ($340.0M vs $270.8M, roughly 1.3× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -12.9%, a 13.6% gap on every dollar of revenue. On growth, Walker & Dunlop, Inc. posted the faster year-over-year revenue change (-0.4% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-680.1M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Walker & Dunlop, Inc. is one of the largest commercial real estate finance and advisory services firms in the United States and internationally.
HCM vs WD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $340.0M |
| Net Profit | $2.0M | $-13.9M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | -17.2% |
| Net Margin | 0.7% | -12.9% |
| Revenue YoY | -16.5% | -0.4% |
| Net Profit YoY | -83.6% | -131.0% |
| EPS (diluted) | $0.00 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $340.0M | ||
| Q3 25 | — | $337.7M | ||
| Q2 25 | $277.7M | $319.2M | ||
| Q1 25 | $324.5M | $237.4M | ||
| Q4 24 | — | $341.5M | ||
| Q3 24 | — | $292.3M | ||
| Q2 24 | $305.7M | $270.7M | ||
| Q1 24 | — | $228.1M |
| Q4 25 | $2.0M | $-13.9M | ||
| Q3 25 | — | $33.5M | ||
| Q2 25 | $455.0M | $34.0M | ||
| Q1 25 | $11.9M | $2.8M | ||
| Q4 24 | — | $44.8M | ||
| Q3 24 | — | $28.8M | ||
| Q2 24 | $25.8M | $22.7M | ||
| Q1 24 | — | $11.9M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.2% | -17.2% | ||
| Q3 25 | — | 13.6% | ||
| Q2 25 | -1.3% | 14.5% | ||
| Q1 25 | -5.0% | 2.2% | ||
| Q4 24 | — | 15.3% | ||
| Q3 24 | — | 12.8% | ||
| Q2 24 | -9.0% | 10.4% | ||
| Q1 24 | — | 6.0% |
| Q4 25 | 0.7% | -12.9% | ||
| Q3 25 | — | 9.9% | ||
| Q2 25 | 163.8% | 10.6% | ||
| Q1 25 | 3.7% | 1.2% | ||
| Q4 24 | — | 13.1% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | 8.4% | 8.4% | ||
| Q1 24 | — | 5.2% |
| Q4 25 | $0.00 | $-0.41 | ||
| Q3 25 | — | $0.98 | ||
| Q2 25 | $0.52 | $0.99 | ||
| Q1 25 | $0.01 | $0.08 | ||
| Q4 24 | — | $1.32 | ||
| Q3 24 | — | $0.85 | ||
| Q2 24 | $0.03 | $0.67 | ||
| Q1 24 | — | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $299.3M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $1.7B |
| Total Assets | $1.8B | $5.1B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $299.3M | ||
| Q3 25 | — | $274.8M | ||
| Q2 25 | $1.4B | $233.7M | ||
| Q1 25 | $836.1M | $181.0M | ||
| Q4 24 | — | $279.3M | ||
| Q3 24 | — | $179.8M | ||
| Q2 24 | $802.5M | $208.1M | ||
| Q1 24 | — | $216.5M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $1.7B | ||
| Q3 25 | — | $1.8B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $759.9M | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | $740.1M | $1.7B | ||
| Q1 24 | — | $1.7B |
| Q4 25 | $1.8B | $5.1B | ||
| Q3 25 | — | $5.8B | ||
| Q2 25 | $1.8B | $4.7B | ||
| Q1 25 | $1.3B | $4.5B | ||
| Q4 24 | — | $4.4B | ||
| Q3 24 | — | $4.6B | ||
| Q2 24 | $1.3B | $4.2B | ||
| Q1 24 | — | $3.8B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-664.3M |
| Free Cash FlowOCF − Capex | $3.4M | $-680.1M |
| FCF MarginFCF / Revenue | 1.2% | -200.0% |
| Capex IntensityCapex / Revenue | 1.8% | 4.6% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $-2.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $-664.3M | ||
| Q3 25 | — | $-948.1M | ||
| Q2 25 | $-72.9M | $-238.5M | ||
| Q1 25 | $40.3M | $-281.1M | ||
| Q4 24 | — | $129.4M | ||
| Q3 24 | — | $-202.0M | ||
| Q2 24 | $-39.8M | $-237.8M | ||
| Q1 24 | — | $38.4M |
| Q4 25 | $3.4M | $-680.1M | ||
| Q3 25 | — | $-950.4M | ||
| Q2 25 | $-82.2M | $-241.0M | ||
| Q1 25 | $32.5M | $-284.7M | ||
| Q4 24 | — | $116.4M | ||
| Q3 24 | — | $-204.0M | ||
| Q2 24 | $-49.9M | $-241.7M | ||
| Q1 24 | — | $35.2M |
| Q4 25 | 1.2% | -200.0% | ||
| Q3 25 | — | -281.5% | ||
| Q2 25 | -29.6% | -75.5% | ||
| Q1 25 | 10.0% | -120.0% | ||
| Q4 24 | — | 34.1% | ||
| Q3 24 | — | -69.8% | ||
| Q2 24 | -16.3% | -89.3% | ||
| Q1 24 | — | 15.4% |
| Q4 25 | 1.8% | 4.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | 3.3% | 0.8% | ||
| Q1 25 | 2.4% | 1.5% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | 3.3% | 1.4% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | -28.34× | ||
| Q2 25 | -0.16× | -7.02× | ||
| Q1 25 | 3.38× | -102.07× | ||
| Q4 24 | — | 2.89× | ||
| Q3 24 | — | -7.01× | ||
| Q2 24 | -1.54× | -10.49× | ||
| Q1 24 | — | 3.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
